Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Transcriptome of Siraitia grosvenorii suspension cells

PROVIDER: PRJNA1028527 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR26394614_1.fastq.gz	Fastqsanger.gz
	SRR26394614_2.fastq.gz	Fastqsanger.gz
	SRR26394615_1.fastq.gz	Fastqsanger.gz
	SRR26394615_2.fastq.gz	Fastqsanger.gz
	SRR26394616_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 12

Similar Datasets

Project description:Siraitia grosvenorii Amplicon

| PRJNA950226 | ENA

Siraitia grosvenorii

Project description:Siraitia grosvenorii Transcriptome or Gene expression

| PRJNA67121 | ENA

Siraitia grosvenorii

Project description:Siraitia grosvenorii Raw sequence reads

| PRJNA339375 | ENA

Siraitia grosvenorii

Project description:triploid and diploid Siraitia grosvenorii Transcriptome or Gene expression

| PRJNA231973 | ENA

Siraitia grosvenorii Eukaryota Viridiplantae Streptophyta Embryophyta Tracheophyta Spermatophyta Magnoliophyta eudicotyledons Gunneridae Pentapetalae rosids fabids Cucurbitales Cucurbitaceae Siraitieae Siraitia.

Project description:The complete chloroplast genome of Siraitia grosvenorii

| PRJNA523890 | ENA

Siraitia grosvenorii strain:NongYuan B6

Project description:Siraitia grosvenorii strain:NongYuan B6 Organism overview

| PRJNA67181 | ENA

Genome sequencing of Siraitia grosvenorii

Project description:PacBio RSII sequencing of Siraitia grosvenorii, Qingpiguo.

| PRJEB23465 | ENA

Project description:Diversity of Arbuscular Mycorrhizal Fungi Community in Siraitia grosvenorii Rhizosphere

| PRJNA1050901 | ENA

Mogrol attenuates osteoclast formation and bone resorption by inhibiting the TRAF6/MAPK/NF-κB signaling pathway in vitro and protects against osteoporosis in postmenopausal mice

Project description:Osteoporosis is a serious public health problem that results in fragility fractures, especially in postmenopausal women. Because the current therapeutic strategy for osteoporosis has various side effects, a safer and more effective treatment is worth exploring. It is important to examine natural plant extracts during new drug design due to low toxicity. Mogrol is an aglycon of mogroside, which is the active component of Siraitia grosvenorii and exhibits anti-inflammatory, anticancer and neuroprotective effects. Here, we demonstrated that mogrol dose-dependently inhibited osteoclast formation and function. To confirm the mechanism, RNA sequencing (RNA-seq), real-time PCR (RT–PCR), immunofluorescence and Western blotting were performed. The RNA-seq data revealed that mogrol had an effect on genes involved in osteoclastogenesis. Furthermore, RT–PCR indicated that mogrol suppressed osteoclastogenesis-related gene expression, including CTSK, ACP5, MMP9 and DC-STAMP, in RANKL-induced bone marrow macrophages (BMMs). Western blotting demonstrated that mogrol suppressed osteoclast formation by blocking TNF receptor-associated factor 6 (TRAF6)-dependent activation of the mitogen-activated protein kinase (MAPK)/nuclear factor-B (NF-κB) signaling pathway, which decreased two vital downstream transcription factors, the nuclear factor of activated T cells calcineurin-dependent 1 (NFATc1) and c-Fos proteins expression. Furthermore, mogrol dramatically reduced bone mass loss in postmenopausal mice. In conclusion, these data showed that mogrol may be a promising procedure for osteoporosis prevention or therapy.

2022-02-18 | GSE196742 | GEO

Project description:Transcriptome analyses of rose suspension cells

| PRJNA916753 | ENA